(Total Views: 738)
Posted On: 09/15/2021 11:20:08 PM
Post# of 155790
Quote:
So, they have nonbinding for $350m. Imo for 7 to 10 million vials.or $2.5B revenue or $150 share price.
Any objection to.my rough estimates? Ohm, others.?
A lot of unknown variables so speculation must be made.
10 million vials @ $200 (1 dose, 2 vials - $400) = $2 billion. 50% split with distributor = $1 billion. $1 billion - $200 million (10% royalties at retail/wholesale) = $800 million. $800 million - $300 million (overheard, distribution and new trials) = $500 million earnings. $500 million x 25 P/E = $12.5 billion market cap. $12.5 billion / 800 million shares = $15.62
Of course the above share price does not reflect the potential from HIV BLA, NASH, longhaulers, cancer and other diseases. Once Cytodyn is known from a Covid EUA FOMO should escalate once investors do due diligence.
(12)
(0)
